HeartSciences (HSCS) Retained Earnings (2022 - 2026)

HeartSciences (HSCS) has reported Retained Earnings for 5 consecutive years, with -$85.3 million the latest figure, recorded in Q2 2026.

• Quarterly Retained Earnings fell 211.75% year-over-year to -$85.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$85.3 million (down 211.75% YoY) and the FY2026 annual result came in at -$85.3 million, down 211.75% from the prior year.
• Retained Earnings slipped to -$85.3 million in Q2 2026 per HSCS's latest filing, from $76.3 million in the prior quarter.
• Over the last five years, Retained Earnings for HSCS reached as high as $84.7 million in Q4 2025 and fell as low as -$85.3 million in Q2 2026.
• A 5-year average of $32.2 million and a median of $74.1 million in 2024 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2024 — Retained Earnings surged 225.3% — and 2026, when it sank 211.75%.
• Year by year, Retained Earnings stood at $58.9 million in 2022, then slumped by 208.57% to -$63.9 million in 2023, then jumped by 218.17% to $75.5 million in 2024, then advanced by 1.08% to $76.3 million in 2025, then plunged by 211.75% to -$85.3 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$85.3 million, $76.3 million, and $84.7 million for Q2 2026, Q4 2025, and Q4 2025 respectively.